{"entity":{"type":"insider","cik":"0001251213","url":"/insider/0001251213","json_url":"/insider/0001251213.json","name":"BENTSUR RON","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":155,"n_filings":96,"first":"2006-03-31","last":"2026-07-01","span_basis":"filed_date"},"name_variants":[{"name":"BENTSUR RON","source":"filing","n_filings":96,"first_seen":"2006-03-31","last_seen":"2026-07-01"}],"transactions":[{"id":5942678,"accession":"0001104659-26-079792","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-079792","line_url":"/filing/0001104659-26-079792#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":3688424.0,"shares_owned_after_display":"3,688,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-01","scope":"insider"},{"id":4327648,"accession":"0001104659-25-107423","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-107423","line_url":"/filing/0001104659-25-107423#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.72,"price_display":"5.72","price_state":"stated","total_value":28600.0,"total_display":"28,600.00","total_whole":"28,600","shares_owned_after":3525924.0,"shares_owned_after_display":"3,525,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-05","filed_date":"2025-11-06","scope":"insider"},{"id":2171599,"accession":"0001104659-24-131541","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-131541","line_url":"/filing/0001104659-24-131541#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":4.65,"price_display":"4.65","price_state":"stated","total_value":20925.0,"total_display":"20,925.00","total_whole":"20,925","shares_owned_after":3270924.0,"shares_owned_after_display":"3,270,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-24","filed_date":"2024-12-26","scope":"insider"},{"id":2472269,"accession":"0001104659-24-119976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-119976","line_url":"/filing/0001104659-24-119976#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.92,"price_display":"4.92","price_state":"stated","total_value":98400.0,"total_display":"98,400.00","total_whole":"98,400","shares_owned_after":3266424.0,"shares_owned_after_display":"3,266,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-15","filed_date":"2024-11-18","scope":"insider"},{"id":2085799,"accession":"0001104659-24-061674","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-061674","line_url":"/filing/0001104659-24-061674#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1940.0,"shares_display":"1,940","price_per_share":6.74,"price_display":"6.74","price_state":"stated","total_value":13075.6,"total_display":"13,075.60","total_whole":"13,076","shares_owned_after":3246424.0,"shares_owned_after_display":"3,246,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-15","scope":"insider"},{"id":2314869,"accession":"0001104659-24-060263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-060263","line_url":"/filing/0001104659-24-060263#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.4,"price_display":"6.40","price_state":"stated","total_value":12800.0,"total_display":"12,800.00","total_whole":"12,800","shares_owned_after":3244484.0,"shares_owned_after_display":"3,244,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-10","filed_date":"2024-05-13","scope":"insider"},{"id":2085733,"accession":"0001104659-24-035902","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-035902","line_url":"/filing/0001104659-24-035902#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":10.29,"price_display":"10.29","price_state":"stated","total_value":51450.0,"total_display":"51,450.00","total_whole":"51,450","shares_owned_after":3242484.0,"shares_owned_after_display":"3,242,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-18","filed_date":"2024-03-19","scope":"insider"},{"id":8534499,"accession":"0001104659-23-108814","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-108814","line_url":"/filing/0001104659-23-108814#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":640.0,"shares_display":"640","price_per_share":11.08,"price_display":"11.08","price_state":"stated","total_value":7091.2,"total_display":"7,091.20","total_whole":"7,091","shares_owned_after":3237484.0,"shares_owned_after_display":"3,237,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-10","filed_date":"2023-10-12","scope":"insider"},{"id":7844426,"accession":"0001104659-23-107889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-107889","line_url":"/filing/0001104659-23-107889#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":830.0,"shares_display":"830","price_per_share":11.19,"price_display":"11.19","price_state":"stated","total_value":9287.7,"total_display":"9,287.70","total_whole":"9,288","shares_owned_after":3236844.0,"shares_owned_after_display":"3,236,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-09","filed_date":"2023-10-10","scope":"insider"},{"id":7844423,"accession":"0001104659-23-107889","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-107889","line_url":"/filing/0001104659-23-107889#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":11.27,"price_display":"11.27","price_state":"stated","total_value":2817.5,"total_display":"2,817.50","total_whole":"2,818","shares_owned_after":3236014.0,"shares_owned_after_display":"3,236,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-06","filed_date":"2023-10-10","scope":"insider"},{"id":8534483,"accession":"0001104659-23-107367","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-107367","line_url":"/filing/0001104659-23-107367#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400.0,"shares_display":"1,400","price_per_share":11.09,"price_display":"11.09","price_state":"stated","total_value":15526.0,"total_display":"15,526.00","total_whole":"15,526","shares_owned_after":3235764.0,"shares_owned_after_display":"3,235,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-05","filed_date":"2023-10-06","scope":"insider"},{"id":8534479,"accession":"0001104659-23-107367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-107367","line_url":"/filing/0001104659-23-107367#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1820.0,"shares_display":"1,820","price_per_share":10.95,"price_display":"10.95","price_state":"stated","total_value":19929.0,"total_display":"19,929.00","total_whole":"19,929","shares_owned_after":3234364.0,"shares_owned_after_display":"3,234,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-04","filed_date":"2023-10-06","scope":"insider"},{"id":8623057,"accession":"0001104659-23-092539","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-092539","line_url":"/filing/0001104659-23-092539#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":115.0,"shares_display":"115","price_per_share":15.15,"price_display":"15.15","price_state":"stated","total_value":1742.25,"total_display":"1,742.25","total_whole":"1,742","shares_owned_after":3232544.0,"shares_owned_after_display":"3,232,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-16","scope":"insider"},{"id":8623055,"accession":"0001104659-23-092539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-092539","line_url":"/filing/0001104659-23-092539#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":235.0,"shares_display":"235","price_per_share":14.34,"price_display":"14.34","price_state":"stated","total_value":3369.9,"total_display":"3,369.90","total_whole":"3,370","shares_owned_after":3232429.0,"shares_owned_after_display":"3,232,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-16","scope":"insider"},{"id":8430019,"accession":"0001104659-23-090650","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-090650","line_url":"/filing/0001104659-23-090650#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":180.0,"shares_display":"180","price_per_share":14.66,"price_display":"14.66","price_state":"stated","total_value":2638.8,"total_display":"2,638.80","total_whole":"2,639","shares_owned_after":3232194.0,"shares_owned_after_display":"3,232,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-11","scope":"insider"},{"id":8430012,"accession":"0001104659-23-090650","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-090650","line_url":"/filing/0001104659-23-090650#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120.0,"shares_display":"120","price_per_share":14.83,"price_display":"14.83","price_state":"stated","total_value":1779.6,"total_display":"1,779.60","total_whole":"1,780","shares_owned_after":3232014.0,"shares_owned_after_display":"3,232,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-08","filed_date":"2023-08-11","scope":"insider"},{"id":7804041,"accession":"0001104659-23-083472","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-083472","line_url":"/filing/0001104659-23-083472#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":225.0,"shares_display":"225","price_per_share":14.85,"price_display":"14.85","price_state":"stated","total_value":3341.25,"total_display":"3,341.25","total_whole":"3,341","shares_owned_after":3231894.0,"shares_owned_after_display":"3,231,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-21","filed_date":"2023-07-24","scope":"insider"},{"id":7804038,"accession":"0001104659-23-083472","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-083472","line_url":"/filing/0001104659-23-083472#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":110.0,"shares_display":"110","price_per_share":15.06,"price_display":"15.06","price_state":"stated","total_value":1656.6,"total_display":"1,656.60","total_whole":"1,657","shares_owned_after":3231669.0,"shares_owned_after_display":"3,231,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-20","filed_date":"2023-07-24","scope":"insider"},{"id":8073106,"accession":"0001104659-23-082535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-082535","line_url":"/filing/0001104659-23-082535#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":14.33,"price_display":"14.33","price_state":"stated","total_value":2866.0,"total_display":"2,866.00","total_whole":"2,866","shares_owned_after":3231559.0,"shares_owned_after_display":"3,231,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-20","scope":"insider"},{"id":8357487,"accession":"0001104659-23-081834","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-081834","line_url":"/filing/0001104659-23-081834#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150.0,"shares_display":"150","price_per_share":15.03,"price_display":"15.03","price_state":"stated","total_value":2254.5,"total_display":"2,254.50","total_whole":"2,255","shares_owned_after":3231359.0,"shares_owned_after_display":"3,231,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-14","filed_date":"2023-07-18","scope":"insider"},{"id":8357483,"accession":"0001104659-23-081834","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-081834","line_url":"/filing/0001104659-23-081834#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":110.0,"shares_display":"110","price_per_share":16.19,"price_display":"16.19","price_state":"stated","total_value":1780.9,"total_display":"1,780.90","total_whole":"1,781","shares_owned_after":3231209.0,"shares_owned_after_display":"3,231,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-07","filed_date":"2023-07-18","scope":"insider"},{"id":7891446,"accession":"0001104659-23-078941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-078941","line_url":"/filing/0001104659-23-078941#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":320.0,"shares_display":"320","price_per_share":14.88,"price_display":"14.88","price_state":"stated","total_value":4761.6,"total_display":"4,761.60","total_whole":"4,762","shares_owned_after":3231099.0,"shares_owned_after_display":"3,231,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-06","filed_date":"2023-07-07","scope":"insider"},{"id":7803958,"accession":"0001104659-23-075030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-075030","line_url":"/filing/0001104659-23-075030#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750.0,"shares_display":"750","price_per_share":16.5,"price_display":"16.50","price_state":"stated","total_value":12375.0,"total_display":"12,375.00","total_whole":"12,375","shares_owned_after":3230779.0,"shares_owned_after_display":"3,230,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-26","filed_date":"2023-06-27","scope":"insider"},{"id":8728984,"accession":"0001104659-23-073568","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-073568","line_url":"/filing/0001104659-23-073568#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":17.88,"price_display":"17.88","price_state":"stated","total_value":8940.0,"total_display":"8,940.00","total_whole":"8,940","shares_owned_after":3230029.0,"shares_owned_after_display":"3,230,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-22","scope":"insider"},{"id":8052517,"accession":"0001104659-23-069566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-069566","line_url":"/filing/0001104659-23-069566#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120.0,"shares_display":"120","price_per_share":17.53,"price_display":"17.53","price_state":"stated","total_value":2103.6,"total_display":"2,103.60","total_whole":"2,104","shares_owned_after":3229529.0,"shares_owned_after_display":"3,229,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-08","scope":"insider"},{"id":8052513,"accession":"0001104659-23-069566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-069566","line_url":"/filing/0001104659-23-069566#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":230.0,"shares_display":"230","price_per_share":17.41,"price_display":"17.41","price_state":"stated","total_value":4004.3,"total_display":"4,004.30","total_whole":"4,004","shares_owned_after":3229409.0,"shares_owned_after_display":"3,229,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-08","scope":"insider"},{"id":7891319,"accession":"0001104659-23-066844","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-066844","line_url":"/filing/0001104659-23-066844#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":330.0,"shares_display":"330","price_per_share":17.28,"price_display":"17.28","price_state":"stated","total_value":5702.4,"total_display":"5,702.40","total_whole":"5,702","shares_owned_after":3229179.0,"shares_owned_after_display":"3,229,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-01","scope":"insider"},{"id":8224625,"accession":"0001104659-23-065198","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-065198","line_url":"/filing/0001104659-23-065198#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":17.49,"price_display":"17.49","price_state":"stated","total_value":3498.0,"total_display":"3,498.00","total_whole":"3,498","shares_owned_after":3228849.0,"shares_owned_after_display":"3,228,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-24","filed_date":"2023-05-26","scope":"insider"},{"id":8534031,"accession":"0001104659-23-062078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-062078","line_url":"/filing/0001104659-23-062078#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":320.0,"shares_display":"320","price_per_share":17.025,"price_display":"17.02","price_state":"stated","total_value":5448.0,"total_display":"5,448.00","total_whole":"5,448","shares_owned_after":3228649.0,"shares_owned_after_display":"3,228,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":8145835,"accession":"0001104659-23-036892","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-036892","line_url":"/filing/0001104659-23-036892#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":230.0,"shares_display":"230","price_per_share":12.13,"price_display":"12.13","price_state":"stated","total_value":2789.9,"total_display":"2,789.90","total_whole":"2,790","shares_owned_after":3228329.0,"shares_owned_after_display":"3,228,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-03-27","scope":"insider"},{"id":8253479,"accession":"0001104659-23-035861","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-035861","line_url":"/filing/0001104659-23-035861#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":480.0,"shares_display":"480","price_per_share":12.08,"price_display":"12.08","price_state":"stated","total_value":5798.4,"total_display":"5,798.40","total_whole":"5,798","shares_owned_after":3228099.0,"shares_owned_after_display":"3,228,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-21","filed_date":"2023-03-23","scope":"insider"},{"id":8367341,"accession":"0001493152-23-008362","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-008362","line_url":"/filing/0001493152-23-008362#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Beyond Air, Inc.","issuer_ticker":"XAIR","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300.0,"shares_display":"2,300","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":14904.0,"total_display":"14,904.00","total_whole":"14,904","shares_owned_after":144736.0,"shares_owned_after_display":"144,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-21","scope":"insider"},{"id":8253450,"accession":"0001104659-23-033354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-033354","line_url":"/filing/0001104659-23-033354#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":480.0,"shares_display":"480","price_per_share":10.91,"price_display":"10.91","price_state":"stated","total_value":5236.8,"total_display":"5,236.80","total_whole":"5,237","shares_owned_after":3227619.0,"shares_owned_after_display":"3,227,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-16","scope":"insider"},{"id":8253447,"accession":"0001104659-23-033354","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-033354","line_url":"/filing/0001104659-23-033354#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1680.0,"shares_display":"1,680","price_per_share":10.85,"price_display":"10.85","price_state":"stated","total_value":18228.0,"total_display":"18,228.00","total_whole":"18,228","shares_owned_after":3227139.0,"shares_owned_after_display":"3,227,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-16","scope":"insider"},{"id":6702346,"accession":"0001104659-22-123312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-123312","line_url":"/filing/0001104659-22-123312#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150.0,"shares_display":"150","price_per_share":7.45,"price_display":"7.45","price_state":"stated","total_value":1117.5,"total_display":"1,117.50","total_whole":"1,118","shares_owned_after":3015459.0,"shares_owned_after_display":"3,015,459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-30","filed_date":"2022-11-30","scope":"insider"},{"id":6636866,"accession":"0001104659-22-122887","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-122887","line_url":"/filing/0001104659-22-122887#line-3","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150.0,"shares_display":"150","price_per_share":7.45,"price_display":"7.45","price_state":"stated","total_value":1117.5,"total_display":"1,117.50","total_whole":"1,118","shares_owned_after":3015309.0,"shares_owned_after_display":"3,015,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-29","filed_date":"2022-11-29","scope":"insider"},{"id":6636864,"accession":"0001104659-22-122887","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-122887","line_url":"/filing/0001104659-22-122887#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150.0,"shares_display":"150","price_per_share":7.4,"price_display":"7.40","price_state":"stated","total_value":1110.0,"total_display":"1,110.00","total_whole":"1,110","shares_owned_after":3015159.0,"shares_owned_after_display":"3,015,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-28","filed_date":"2022-11-29","scope":"insider"},{"id":6636858,"accession":"0001104659-22-122887","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-122887","line_url":"/filing/0001104659-22-122887#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150.0,"shares_display":"150","price_per_share":7.38,"price_display":"7.38","price_state":"stated","total_value":1107.0,"total_display":"1,107.00","total_whole":"1,107","shares_owned_after":3015009.0,"shares_owned_after_display":"3,015,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-25","filed_date":"2022-11-29","scope":"insider"},{"id":6883876,"accession":"0001104659-22-120514","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-120514","line_url":"/filing/0001104659-22-120514#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":7.23,"price_display":"7.23","price_state":"stated","total_value":3615.0,"total_display":"3,615.00","total_whole":"3,615","shares_owned_after":3014859.0,"shares_owned_after_display":"3,014,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-21","scope":"insider"},{"id":6883872,"accession":"0001104659-22-120514","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-120514","line_url":"/filing/0001104659-22-120514#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":7.24,"price_display":"7.24","price_state":"stated","total_value":1810.0,"total_display":"1,810.00","total_whole":"1,810","shares_owned_after":3014359.0,"shares_owned_after_display":"3,014,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-21","scope":"insider"},{"id":6418947,"accession":"0001104659-22-119361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-119361","line_url":"/filing/0001104659-22-119361#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.07,"price_display":"7.07","price_state":"stated","total_value":7070.0,"total_display":"7,070.00","total_whole":"7,070","shares_owned_after":3014109.0,"shares_owned_after_display":"3,014,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-10","filed_date":"2022-11-16","scope":"insider"},{"id":6770925,"accession":"0001104659-22-104928","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-104928","line_url":"/filing/0001104659-22-104928#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":7.46,"price_display":"7.46","price_state":"stated","total_value":3730.0,"total_display":"3,730.00","total_whole":"3,730","shares_owned_after":3013109.0,"shares_owned_after_display":"3,013,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-03","scope":"insider"},{"id":6770921,"accession":"0001104659-22-104928","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-104928","line_url":"/filing/0001104659-22-104928#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":7.23,"price_display":"7.23","price_state":"stated","total_value":3615.0,"total_display":"3,615.00","total_whole":"3,615","shares_owned_after":3012609.0,"shares_owned_after_display":"3,012,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-10-03","scope":"insider"},{"id":6110114,"accession":"0001104659-22-103162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-103162","line_url":"/filing/0001104659-22-103162#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":7.69,"price_display":"7.69","price_state":"stated","total_value":3845.0,"total_display":"3,845.00","total_whole":"3,845","shares_owned_after":3012109.0,"shares_owned_after_display":"3,012,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-26","filed_date":"2022-09-27","scope":"insider"},{"id":6110112,"accession":"0001104659-22-103162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-103162","line_url":"/filing/0001104659-22-103162#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.93,"price_display":"7.93","price_state":"stated","total_value":7930.0,"total_display":"7,930.00","total_whole":"7,930","shares_owned_after":3011609.0,"shares_owned_after_display":"3,011,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-23","filed_date":"2022-09-27","scope":"insider"},{"id":6214921,"accession":"0001104659-22-097694","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-097694","line_url":"/filing/0001104659-22-097694#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":8.37,"price_display":"8.37","price_state":"stated","total_value":10044.0,"total_display":"10,044.00","total_whole":"10,044","shares_owned_after":3010609.0,"shares_owned_after_display":"3,010,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-06","scope":"insider"},{"id":6214917,"accession":"0001104659-22-097694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-097694","line_url":"/filing/0001104659-22-097694#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":8.11,"price_display":"8.11","price_state":"stated","total_value":4055.0,"total_display":"4,055.00","total_whole":"4,055","shares_owned_after":3009409.0,"shares_owned_after_display":"3,009,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider"},{"id":6110058,"accession":"0001104659-22-095830","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-095830","line_url":"/filing/0001104659-22-095830#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.07,"price_display":"9.07","price_state":"stated","total_value":9070.0,"total_display":"9,070.00","total_whole":"9,070","shares_owned_after":3008909.0,"shares_owned_after_display":"3,008,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-29","filed_date":"2022-08-30","scope":"insider"},{"id":6110055,"accession":"0001104659-22-095830","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-095830","line_url":"/filing/0001104659-22-095830#line-1","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":4500.0,"total_display":"4,500.00","total_whole":"4,500","shares_owned_after":3007909.0,"shares_owned_after_display":"3,007,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-23","filed_date":"2022-08-30","scope":"insider"},{"id":6418794,"accession":"0001104659-22-093128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-093128","line_url":"/filing/0001104659-22-093128#line-2","is_derivative":false,"issuer_cik":"0001251213","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001251213","owner_cik":"0001251213","owner_name":"BENTSUR RON","owner_display_name":"BENTSUR RON","owner_url":"/insider/0001251213","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":8.99,"price_display":"8.99","price_state":"stated","total_value":44950.0,"total_display":"44,950.00","total_whole":"44,950","shares_owned_after":3007409.0,"shares_owned_after_display":"3,007,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-19","filed_date":"2022-08-22","scope":"insider"}],"collapsed":true,"next_cursor":"2022-08-19|6418794","ledger_fault":false,"count":{"value":155,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":91,"open_market":true},{"code":"S","label":"Open-market sale","n":64,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":155},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001875558","name":"Nuvectis Pharma, Inc.","url":"/issuer/0001875558","role":"Director, Officer (Chairman & CEO), Ten percent owner","n_filings":47,"first_seen":"2022-02-08","last_seen":"2026-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001641631","name":"Beyond Air, Inc.","url":"/issuer/0001641631","role":"Director","n_filings":20,"first_seen":"2020-07-31","last_seen":"2023-03-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001114220","name":"KERYX BIOPHARMACEUTICALS INC","url":"/issuer/0001114220","role":"Director, Officer (Chief Executive Officer)","n_filings":26,"first_seen":"2006-03-31","last_seen":"2015-04-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001264587","name":"STEMLINE THERAPEUTICS INC","url":"/issuer/0001264587","role":"Director","n_filings":1,"first_seen":"2015-03-20","last_seen":"2015-03-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001023549","name":"XTL BIOPHARMACEUTICALS LTD","url":"/issuer/0001023549","role":"Officer (CEO)","n_filings":2,"first_seen":"2006-08-28","last_seen":"2007-08-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001251213","retrieved_at":"2026-08-27T04:54:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}